|
TMO
|
Healthcare |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$168.8B
|
$263.09
|
-0.0%
|
+0.2%
|
+0.9%
|
-0.1%
|
+2.0%
|
-2.7%
|
|
FDX
|
Industrials |
Raymond James |
Maintains
|
Outperform
→
Outperform
|
—
|
$91.1B
|
$177.98
|
+0.1%
|
+2.5%
|
-0.5%
|
-3.5%
|
+2.2%
|
-2.8%
|
|
JCI
|
Industrials |
Wells FargoB |
Upgrade
|
Market Perform
→
Outperform
|
—
|
$88.6B
|
$35.83
|
+1.9%
|
+1.6%
|
-0.1%
|
+0.0%
|
+1.6%
|
-2.2%
|
|
CP
|
Industrials |
Deutsche Bank |
Maintains
|
Buy
→
Buy
|
—
|
$79.0B
|
$41.06
|
-0.3%
|
+0.6%
|
-1.9%
|
-1.0%
|
+1.5%
|
-1.6%
|
|
NKE
|
Consumer Cyclical |
Credit Suisse |
Maintains
|
Outperform
→
Outperform
|
—
|
$63.1B
|
$86.80
|
+0.6%
|
+1.2%
|
-0.1%
|
-1.1%
|
+1.5%
|
-6.6%
|
|
D
|
Utilities |
Macquarie |
Downgrade
|
Outperform
→
Neutral
|
—
|
$58.3B
|
$77.04
|
+0.1%
|
-0.6%
|
-1.9%
|
-0.3%
|
+0.2%
|
+0.5%
|
|
EW
|
Healthcare |
BofA Securities |
Maintains
|
Buy
→
Buy
|
—
|
$48.1B
|
$59.92
|
+8.2%
|
+6.2%
|
-0.8%
|
-0.2%
|
+1.7%
|
-1.6%
|
|
EW
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$48.1B
|
$59.92
|
+8.2%
|
+6.2%
|
-0.8%
|
-0.2%
|
+1.7%
|
-1.6%
|
|
CMG
|
Consumer Cyclical |
Piper Sandler |
Maintains
|
Overweight
→
Overweight
|
—
|
$44.4B
|
$12.78
|
+0.7%
|
+2.7%
|
+1.5%
|
+0.0%
|
+0.7%
|
+0.1%
|
|
IQV
|
Healthcare |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$30.0B
|
$141.53
|
-1.0%
|
+1.1%
|
+1.0%
|
-0.8%
|
+0.7%
|
-1.8%
|
|
DG
|
Consumer Defensive |
BarclaysB |
Upgrade
|
Equal Weight
→
Overweight
|
—
|
$22.9B
|
$113.89
|
+1.5%
|
+2.3%
|
+0.6%
|
-0.1%
|
+0.6%
|
-0.3%
|
|
ULTA
|
Consumer Cyclical |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$21.7B
|
$338.41
|
+0.1%
|
+1.1%
|
-2.3%
|
-1.1%
|
+1.3%
|
-1.4%
|
|
ULTA
|
Consumer Cyclical |
Loop Capital |
Maintains
|
Hold
→
Hold
|
—
|
$21.7B
|
$338.41
|
+0.1%
|
+1.1%
|
-2.3%
|
-1.1%
|
+1.3%
|
-1.4%
|
|
DGX
|
Healthcare |
Credit Suisse |
Downgrade
|
Outperform
→
Neutral
|
—
|
$21.5B
|
$88.45
|
-0.6%
|
+0.3%
|
+0.8%
|
-0.9%
|
+1.1%
|
-0.4%
|
|
LH
|
Healthcare |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$21.3B
|
$132.61
|
+0.4%
|
+0.3%
|
+0.7%
|
-1.2%
|
+1.4%
|
-1.3%
|
|
WSM
|
Consumer Cyclical |
JP Morgan |
Maintains
|
Underweight
→
Underweight
|
—
|
$21.2B
|
$28.10
|
-0.5%
|
+0.4%
|
+0.5%
|
+0.2%
|
+4.2%
|
-3.7%
|
|
RL
|
Consumer Cyclical |
JP Morgan |
Maintains
|
Overweight
→
Overweight
|
—
|
$20.5B
|
$120.78
|
+0.6%
|
+2.8%
|
+0.5%
|
-1.7%
|
+1.5%
|
-3.5%
|
|
YUMC
|
Consumer Cyclical |
JP Morgan |
Maintains
|
Overweight
→
Overweight
|
—
|
$16.3B
|
$42.70
|
+0.9%
|
+1.9%
|
+0.0%
|
-0.7%
|
+0.1%
|
+0.5%
|
|
OKTA
|
Technology |
Goldman SachsB |
Upgrade
|
Neutral
→
Buy
|
—
|
$15.4B
|
$79.21
|
+5.0%
|
+4.6%
|
-2.0%
|
+0.7%
|
+4.5%
|
-5.2%
|
|
HTHT
|
Consumer Cyclical |
Morgan Stanley |
Downgrade
|
Equal Weight
→
Underweight
|
—
|
$14.9B
|
$39.04
|
-1.6%
|
+0.9%
|
+3.5%
|
-1.2%
|
-1.3%
|
-1.8%
|